Updated: March 19, 2021 BPOM encourages self-reliance in human cell-based drug production Must Read Nationalindonesianupdates.com_admin - April 13, 2025Indonesia gets additional quota of 2,210 Hajj officers: Minister Nationalindonesianupdates.com_admin - April 13, 2025Dharma values foundation for building future leadership: SOEs Ministry Nationalindonesianupdates.com_admin - April 13, 2025Free education in SW Papua covers public, private schools: governor The Drug and Food Control Agency (BPOM) has unveiled a guide to develop and produce human cell-based medicines to encourage domestic pharmaceutical companies to become self-reliant in drug production. “This guide also … Previous articleKadin confirms 3.5 million registered for self-funded vaccinationNext articleGovernment should not delay and pay holiday allowance for 2021: KSPI Latest News National - April 13, 2025Indonesia gets additional quota of 2,210 Hajj officers: MinisterThe Indonesian government has received confirmation of an additional quota of 2,210 Hajj officers from the Saudi ... National Dharma values foundation for building future leadership: SOEs Ministry - April 13, 2025 National Free education in SW Papua covers public, private schools: governor - April 13, 2025 National No health service disruption at Unpad PPDS temporary suspension: govt - April 13, 2025 National President Prabowo witnesses signing of MoU in Qatar - April 13, 2025 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
The Drug and Food Control Agency (BPOM) has unveiled a guide to develop and produce human cell-based medicines to encourage domestic pharmaceutical companies to become self-reliant in drug production.